Myostatin (Mstn) has been described as a trigger for the progression of atherosclerosis. In this study, we evaluated the role of Mstn in arterial remodeling in patients with end-stage renal disease (ESRD).
Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease
Esposito, Pasquale;Verzola, Daniela;Porta, Edoardo La;Milanesi, Samantha;Garibotto, Giacomo
2020-01-01
Abstract
Myostatin (Mstn) has been described as a trigger for the progression of atherosclerosis. In this study, we evaluated the role of Mstn in arterial remodeling in patients with end-stage renal disease (ESRD).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
JAT MYO 2020 def.pdf
accesso aperto
Tipologia:
Documento in versione editoriale
Dimensione
4.3 MB
Formato
Adobe PDF
|
4.3 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
